価格表

在庫・価格 : 2024年05月04日 03時16分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Survivin, Human, DuoSet IC Kit (2 plates)
データシート※最新のデータシートでない場合があります
DYC647-2 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥83,000
(未発注)
追加

在庫・価格 : 2024年05月04日 03時16分 現在

Survivin, Human, DuoSet IC Kit (2 plates)

  • 商品コード:DYC647-2
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥83,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kappler M et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin. Cancer Res. 2003 Mar;9(3):1098-104
Kappler M et al
2003/01/01
Sample Type: Cell Supernates PubMed
2 Fuessel S et al. Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells. J. Urol. 2004 Jun;171(6 Pt 1):2471-6
Fuessel S et al
2004/01/01
Species: Human, Sample type: Cell Lysates PubMed
3 Krysan K et al. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep;64(18):6359-62
Krysan K et al
2004/01/01
Species: Human, Sample type: Cell Lysates PubMed
4 Ning S et al. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int. J. Oncol. 2004 Oct;25(4):1065-71
Ning S et al
2004/01/01
Sample Type: Whole Cells PubMed
5 Bokarewa M et al. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res. Ther. 2005;7(2):R349-58
Bokarewa M et al
2005/01/01
Species: Human, Sample type: Plasma (Citrate), Synovial Fluid PubMed
6 Mera S et al. Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. J. Leukoc. Biol. 2008 Jan;83(1):149-55
Mera S et al
2008/01/01
Species: Human, Sample type: Plasma (Heparin) PubMed
7 Hansen JB et al. SPC3042: a proapoptotic survivin inhibitor. Mol. Cancer Ther. 2008 Sep;7(9):2736-45
Hansen JB et al
2008/01/01
Sample Type: Cell Lysates PubMed
8 Diakos C et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood 2010 Dec;116(23):4885-93
Diakos C et al
2010/01/01
Sample Type: Cell Lysates PubMed
9 Andersson SE et al. Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis. PLoS ONE 2012;7(10):e47668
Andersson SE et al
2012/01/01
Sample Type: Cell Culture Supernates,Cell Lysates,Plasma,Synovial Fluid PubMed
10 Toosi S et al. Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus. J. Invest. Dermatol. 2011 Nov;131(11):2327-9
Toosi S et al
2011/01/01
Sample Type: Serum PubMed
11 Levitsky A et al. Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial. BMC Med 2015;13:247
Levitsky A et al
2015/01/01
Sample Type: Serum PubMed
12 Oparina N et al. Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts. Cancers (Basel) 2021 May;13(9)
Oparina N et al
2021/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Kappler M et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin. Cancer Res. 2003 Mar;9(3):1098-104
    Kappler M et al
    2003/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Fuessel S et al. Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells. J. Urol. 2004 Jun;171(6 Pt 1):2471-6
    Fuessel S et al
    2004/01/01
  • 備考:
    Species: Human, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Krysan K et al. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep;64(18):6359-62
    Krysan K et al
    2004/01/01
  • 備考:
    Species: Human, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ning S et al. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int. J. Oncol. 2004 Oct;25(4):1065-71
    Ning S et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Bokarewa M et al. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res. Ther. 2005;7(2):R349-58
    Bokarewa M et al
    2005/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Citrate), Synovial Fluid
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Mera S et al. Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. J. Leukoc. Biol. 2008 Jan;83(1):149-55
    Mera S et al
    2008/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Hansen JB et al. SPC3042: a proapoptotic survivin inhibitor. Mol. Cancer Ther. 2008 Sep;7(9):2736-45
    Hansen JB et al
    2008/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Diakos C et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood 2010 Dec;116(23):4885-93
    Diakos C et al
    2010/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Andersson SE et al. Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis. PLoS ONE 2012;7(10):e47668
    Andersson SE et al
    2012/01/01
  • 備考:
    Sample Type: Cell Culture Supernates,Cell Lysates,Plasma,Synovial Fluid
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Toosi S et al. Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus. J. Invest. Dermatol. 2011 Nov;131(11):2327-9
    Toosi S et al
    2011/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Levitsky A et al. Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial. BMC Med 2015;13:247
    Levitsky A et al
    2015/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Oparina N et al. Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts. Cancers (Basel) 2021 May;13(9)
    Oparina N et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed